To subscribe to our optical e-newsletters and receive them via e-mail, click here.
A more nuanced understanding of crosslinking, better treatments for dry eye and new thinking about transplants mark this year’s ARVO output.
Fuchs’ corneal dystrophy comes in a variety of intensities, with signs that even skilled observers may miss.
Rising costs, tighter regulation and new technology are changing the traditional eye bank model.
Four surgeons discuss the risks and address the unanswered questions still associated with this procedure.